(secondQuint)Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients.

 Subjects are identified based on whether they received tofacitinib in 2 completed Phase 2 studies who either discontinued treatment prematurely or who did not elect to enroll in long-term extension studies.

 Subjects are pre-identified.

 Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients@highlight

This is an observational study designed to collect follow-up clinical date on subjects who were treated with tofacitinib in 2 completed Phase 2 studies who either discontinued treatment prematurely or did not elect to enroll in long-term extension studies.

